What is the preferred diuretic strategy when a patient is diuretic-resistant with persistent edema?

• A. Increase loop diuretic dose alone.
• B. Discontinue diuretics and start vasodilators.
• C. Combine loop diuretics with a thiazide-type diuretic (e.g., metolazone) or escalate to IV diuretics or consider ultrafiltration.
• D. Add sodium restriction without diuresis.

Answer: (C)

When diuretic resistance occurs in heart failure, the preferred approach is to use a combination strategy that targets different parts of the nephron to maximize sodium loss. Loop diuretics block sodium reabsorption in the thick ascending limb, but if the distal nephron compensates by reabsorbing more sodium, the diuretic effect wanes. Adding a thiazide-type diuretic (like metolazone) inhibits the distal tubule’s NaCl transporter, producing a synergistic and more robust diuresis that often overcomes resistance. If the response remains inadequate or a rapid, strong effect is needed, escalating to intravenous diuretics can achieve higher, more reliable plasma concentrations, or ultrafiltration can physically remove excess fluid when pharmacologic diuresis fails. In contrast, simply increasing the loop dose can amplify side effects and still be limited by distal nephron compensation; stopping diuretics and starting vasodilators or restricting sodium without promoting diuresis won’t effectively relieve edema.